Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus

Journal of Autoimmunity

Volumn 36, Issue 3-4, 2011, Pages 173-180

  Ullal, Anirudh J ^a   Reich, Charles F ^a   Clowse, Megan ^a   Criscione Schreiber, Lisa G ^a   Tochacek, Martin ^a   Monestier, Marc ^b   Pisetsky, David S ^a,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Anti DNA; Anti nucleosome; Immune complex; Microparticle; Systemic lupus erythematosus

Indexed keywords

DEOXYRIBONUCLEASE; DNA ANTIBODY; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; NUCLEOSOME ANTIBODY; STAUROSPORINE;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ANTIGENICITY; APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; MALE; MEMBRANE MICROPARTICLE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; ULTRAVIOLET RADIATION;

ANTIBODIES, ANTINUCLEAR; APOPTOSIS; CELL LINE; CELL-DERIVED MICROPARTICLES; DNA; HUMANS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; NUCLEOSOMES;

EID: 79954950134     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2011.02.001     Document Type: Article

References (38)

1. Rahman A., Isenberg D.A. Systemic lupus erythematosus. N Engl J Med 2008, 358(9):929-939.
2. Ardoin S.P., Pisetsky D.S. Developments in the scientific understanding of lupus. Arthritis Res Ther 2008, 10(5):218.
3. Hahn B.H. Antibodies to DNA. N Engl J Med 1998, 338(19):1359-1368.
4. Waldman M., Madaio M.P. Pathogenic autoantibodies in lupus nephritis. Lupus 2005, 14(1):19-24.
5. Mortensen E.S., Fenton K.A., Rekvig O.P. Lupus nephritis: the central role of nucleosomes revealed. Am J Pathol 2008, 172(2):275-283.
6. van Bavel C.C., Fenton K.A., Rekvig O.P., van der Vlag J., Berden J.H. Glomerular targets of nephritogenic autoantibodies in systemic lupus erythematosus. Arthritis Rheum 2008, 58(7):1892-1899.
7. Radic M.Z., Weigert M. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol 1994, 12:487-520.
8. Wellmann U., Letz M., Herrmann M., Angermuller S., Kalden J.R., Winkler T.H. The evolution of human anti-double-stranded DNA autoantibodies. Proc Natl Acad Sci U S A 2005, 102(26):9258-9263.
9. Zhang J., Jacobi A.M., Wang T., Diamond B. Pathogenic autoantibodies in systemic lupus erythematosus are derived from both self-reactive and non-self-reactive B cells. Mol Med 2008, 14(11-12):675-681.
10. Deane J.A., Bolland S. Nucleic acid-sensing TLRs as modifiers of autoimmunity. J Immunol 2006, 177(10):6573-6578.
11. Marshak-Rothstein A., Rifkin I.R. Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annu Rev Immunol 2007, 25:419-441.
12. Xiao T. Innate immune recognition of nucleic acids. Immunol Res 2009, 43(1-3):98-108.
13. Rönnblom L., Eloranta M.L., Alm G.V. The type I interferon system in systemic lupus erythematosus. Arthritis Rheum 2006, 54(2):408-420.
14. Lovgren T., Eloranta M.L., Bave U., Alm G.V., Rönnblom L. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum 2004, 50(6):1861-1872.
15. Boule M.W., Broughton C., Mackay F., Akira S., Marshak-Rothstein A., Rifkin I.R. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med 2004, 199(12):1631-1640.
16. Means T.K., Latz E., Hayashi F., Murali M.R., Golenbock D.T., Luster A.D. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest 2005, 115(2):407-417.
17. Tian J., Avalos A.M., Mao S.Y., Chen B., Senthil K., Wu H., et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007, 8(5):487-496.
18. Munoz L.E., van Bavel C., Franz S., Berden J., Herrmann M., van der Vlag J. Apoptosis in the pathogenesis of systemic lupus erythematosus. Lupus 2008, 17(5):371-375.
19. Casciola-Rosen L.A., Anhalt G., Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994, 179(4):1317-1330.
20. Cocca B.A., Cline A.M., Radic M.Z. Blebs and apoptotic bodies are B cell autoantigens. J Immunol 2002, 169(1):159-166.
21. Lane J.D., Allan V.J., Woodman P.G. Active relocation of chromatin and endoplasmic reticulum into blebs in late apoptotic cells. J Cell Sci 2005, 118(Pt 17):4059-4071.
22. Schiller M., Bekeredjian-Ding I., Heyder P., Blank N., Ho A.D., Lorenz H.M. Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis. Cell Death Differ 2008, 15(1):183-191.
23. Charras G.T. A short history of blebbing. J Microsc 2008, 231:466-478.
24. Cocucci E., Racchetti G., Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol 2009, 19(2):43-51.
25. Thery C., Ostrowski M., Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immun 2009, 9(8):581-593.
26. Beyer C., Pisetsky D.S. The role of microparticles in the pathogenesis of rheumatic diseases. Nat Rev Rheumatol 2010, 6(1):21-29.
27. Reich C.F., Pisetsky D.S. The content of DNA and RNA in microparticles released by Jurkat and HL-60 cells undergoing in vitro apoptosis. Exp Cell Res 2009, 315(5):760-768.
28. Losman J.A., Fasy T.M., Novick K.E., Massa M., Monestier M. Nucleosome-specific antibody from an autoimmune MRL/Mp-lpr/lpr mouse. Arthritis Rheum 1993, 36(4):552-560.
29. Losman M.J., Fasy T.M., Novick K.E., Monestier M. Monoclonal autoantibodies to subnucleosomes from a MRL/Mp(-)+/+ mouse. Oligoclonality of the antibody response and recognition of a determinant composed of histones H2A, H2B, and DNA. J Immunol 1992, 148(5):1561-1569.
30. Monestier M., Novick K.E., Losman M.J. d-penicillamine- and quinidine-induced antinuclear antibodies in A.SW (H-2s) mice: similarities with autoantibodies in spontaneous and heavy metal-induced autoimmunity. Eur J Immunol 1994, 24(3):723-730.
31. Kramers K., Stemmer C., Monestier M., van Bruggen M.C., Rijke-Schilder T.P., Hylkema M.N., et al. Specificity of monoclonal anti-nucleosome auto-antibodies derived from lupus mice. J Autoimmun 1996, 9(6):723-729.
32. Monestier M., Decker P., Briand J.P., Gabriel J.L., Muller S. Molecular and structural properties of three autoimmune IgG monoclonal antibodies to histone H2B. J Biol Chem 2000, 275(18):13558-13563.
33. Ullal A.J., Pisetsky D.S. The release of microparticles by Jurkat leukemia T cells treated with staurosporine and related kinase inhibitors to induce apoptosis. Apoptosis 2010, 15(5):586-596.
34. Kolowos W., Gaipl U.S., Sheriff A., Voll R.E., Heyder P., Kern P., et al. Microparticles shed from different antigen-presenting cells display an individual pattern of surface molecules and a distinct potential of allogeneic T-cell activation. Scand J Immunol 2005, 61(3):226-233.
35. Bernimoulin M., Waters E.K., Foy M., Steele B.M., Sullivan M., Falet H., et al. Differential stimulation of monocytic cells results in distinct populations of microparticles. J Thromb Haemost 2009, 7(6):1019-1028.
36. Sellam J., Proulle V., Jüngel A., Ittah M., Miceli Richard C., Gottenberg J.E., et al. Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther 2009, 11(5):R156-R166.
37. Biro E., Nieuwland R., Tak P.P., Pronk L.M., Schaap M.C., Sturk A., et al. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals. Ann Rheum Dis 2007, 66(8):1085-1092.
38. Zhu F.G., Reich C.F., Pisetsky D.S. Effect of cytofectins on the immune response of murine macrophages to mammalian DNA. Immunology 2003, 109(2):255-262.